Change search
ReferencesLink to record
Permanent link

Direct link
High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia
Show others and affiliations
Number of Authors: 9
2015 (English)In: Haematologica (online), ISSN 0390-6078, E-ISSN 1592-8721, Vol. 100, no 6, E223-E225 p.Article in journal, Letter (Refereed) Published
Place, publisher, year, edition, pages
2015. Vol. 100, no 6, E223-E225 p.
Keyword [en]
myelodysplastic syndromes, acute myeloid leukemia, secondary, therapy-related, high-throughput mutational screening
National Category
URN: urn:nbn:se:su:diva-120482DOI: 10.3324/haematol.2014.118034ISI: 000358577000003OAI: diva2:853215
Available from: 2015-09-11 Created: 2015-09-10 Last updated: 2015-09-11Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Unneberg, Per
By organisation
Department of Biochemistry and BiophysicsScience for Life Laboratory (SciLifeLab)
In the same journal
Haematologica (online)

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 34 hits
ReferencesLink to record
Permanent link

Direct link